CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 16 | 19 | +3 |
| Shares | 335.3K | 972.6K | +637.4K (+190.1%) |
| Value | $425.3K | $351.0K | −$74.3K (−17.5%) |
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 91,034 | $33.0K | 0.00% |
| Jane Street Group, LLC | 27,388 | $9.91K | 0.00% |
| Two Sigma Securities, LLC | 21,806 | $7.89K | 0.00% |
| HRT Financial LP | 21,898 | $7.00K | 0.00% |
Sold out (1)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 11,144 | $14.0K |